Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 3
2014 1
2015 3
2016 2
2017 1
2018 1
2020 4
2021 2
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
β3 Adrenoceptor Agonism Prevents Hyperoxia-Induced Colonic Alterations.
Filippi L, Nardini P, Zizi V, Molino M, Fazi C, Calvani M, Carrozzo F, Cavallaro G, Giuseppetti G, Calosi L, Crociani O, Pini A. Filippi L, et al. Among authors: calosi l. Biomolecules. 2023 Dec 6;13(12):1755. doi: 10.3390/biom13121755. Biomolecules. 2023. PMID: 38136626 Free PMC article.
Musculin does not modulate the disease course of Experimental Autoimmune Encephalomyelitis and DSS colitis.
Vanni A, Carnasciali A, Mazzoni A, Russo E, Farahvachi P, Gloria LD, Ramazzotti M, Lamacchia G, Capone M, Salvati L, Calosi L, Bani D, Liotta F, Cosmi L, Amedei A, Ballerini C, Maggi L, Annunziato F. Vanni A, et al. Among authors: calosi l. Immunol Lett. 2023 Mar;255:21-31. doi: 10.1016/j.imlet.2023.02.006. Epub 2023 Feb 26. Immunol Lett. 2023. PMID: 36848960 Free article.
Development of Lyophilised Eudragit® Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration.
Lombardo R, Ruponen M, Rautio J, Ghelardini C, Di Cesare Mannelli L, Calosi L, Bani D, Lampinen R, Kanninen KM, Koivisto AM, Penttilä E, Löppönen H, Pignatello R. Lombardo R, et al. Among authors: calosi l. Pharmaceutics. 2023 May 21;15(5):1554. doi: 10.3390/pharmaceutics15051554. Pharmaceutics. 2023. PMID: 37242796 Free PMC article.
Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study.
Micheli L, Di Cesare Mannelli L, Lucarini E, Parisio C, Toti A, Fiorentino B, Rigamonti MA, Calosi L, Ghelardini C. Micheli L, et al. Among authors: calosi l. Front Pharmacol. 2020 Sep 18;11:576624. doi: 10.3389/fphar.2020.576624. eCollection 2020. Front Pharmacol. 2020. PMID: 33071790 Free PMC article.
Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity.
Mangoni M, Sottili M, Gerini C, Fucci R, Pini A, Calosi L, Bonomo P, Detti B, Greto D, Meattini I, Simontacchi G, Loi M, Scartoni D, Furfaro I, Pallotta S, Livi L. Mangoni M, et al. Among authors: calosi l. Anticancer Res. 2015 Jul;35(7):3875-84. Anticancer Res. 2015. PMID: 26124333
Optimization of an Ex-Vivo Human Skin/Vein Model for Long-Term Wound Healing Studies: Ground Preparatory Activities for the 'Suture in Space' Experiment Onboard the International Space Station.
Cialdai F, Bacci S, Zizi V, Norfini A, Balsamo M, Ciccone V, Morbidelli L, Calosi L, Risaliti C, Vanhelden L, Pantalone D, Bani D, Monici M. Cialdai F, et al. Among authors: calosi l. Int J Mol Sci. 2022 Nov 16;23(22):14123. doi: 10.3390/ijms232214123. Int J Mol Sci. 2022. PMID: 36430601 Free PMC article.
21 results